Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Calidi Biotherapeutics Inc CLDI

Alternate Symbol(s): CLDWW

Healthcare Biotechnology

Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's novel stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Its clinical-stage off-the-shelf... see more

Add To Watchlist

Recent & Breaking News (NYSEAM:CLDI)

Calidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officer

Business Wire October 30, 2023

Calidi Biotherapeutics To Present New Preclinical Data Highlighting Cell-based Virotherapy (SuperNova) Platform Technology at SITC 2023

Business Wire October 10, 2023

Calidi Biotherapeutics Debuts as a Publicly Traded Company Focused on Arming the Immune System to Fight Cancer with a New Generation of Targeted Immunotherapies

GlobeNewswire September 13, 2023

First Light Acquisition Group Announces NYSE Approval for Listing of Business Combination with Calidi Biotherapeutics and Additional New Capital Commitments

GlobeNewswire September 11, 2023

FIRST LIGHT ACQUISITION GROUP, INC. Further Adjourns Special Meeting of Stockholders to August 28, 2023 at 10:30 am ET

GlobeNewswire August 24, 2023

FIRST LIGHT ACQUISITION GROUP, INC. Adjourns Special Meeting of Stockholders to August 24, 2023 at 10:30 am ET

GlobeNewswire August 22, 2023

Flag Stockholders: Reminder to Vote for Proposed Business Combination

GlobeNewswire August 16, 2023

First Light Acquisition Group, Inc. Announces Effectiveness of Registration Statement and Sets August 22, 2023 as Date of Stockholder Meeting for the Calidi Business Combination

GlobeNewswire August 7, 2023

Calidi Biotherapeutics Announces Commitment of $25 Million in Series B Funding to Advance Stem Cell-Based Platforms for the Delivery and Potentiation of Oncolytic Viruses to Treat Cancer

GlobeNewswire June 23, 2023

Calidi Biotherapeutics and First Light Acquisition Group (FLAG) Announce Merger Agreement to Create a Publicly Listed, Clinical-Stage Biotechnology Company Utilizing Stem Cell-Based Platforms to Revolutionize Oncolytic Virotherapies

GlobeNewswire January 9, 2023

First Light Acquisition Group, Inc. Announces Approval of Extension Amendment to Certificate of Incorporation

GlobeNewswire December 15, 2022

CORRECTION - First Light Acquisition Group, Inc. Transfers Listing to NYSE American LLC

GlobeNewswire November 14, 2022

First Light Acquisition Group, Inc. Transfers Listing to NYSE American LLC

GlobeNewswire November 14, 2022

First Light Acquisition Group, Inc. Announces Approval of Extension Amendment to Certificate of Incorporation

GlobeNewswire September 16, 2022

FIRST LIGHT ACQUISITION GROUP, INC. Adjourns Special Meeting of Stockholders to September 13, 2022 at 10:00 am ET

GlobeNewswire September 9, 2022

First Light Acquisition Group, Inc. Announces the Separate Trading of its shares of Class A Common Stock and Warrants, Commencing November 1, 2021

GlobeNewswire October 28, 2021